Phase 3 Randomized, Controlled Study of Blinatumomab Alternating with Low-intensity Chemotherapy Versus Standard of Care for Older Adults with Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia with Safety Run-in (Golden Gate Study)

  • Fleming, Shaun Alan (Primary Chief Investigator (PCI))
  • Cannell, Paul (Chief Investigator (CI))
  • Yeung, David T (Chief Investigator (CI))
  • Mapp, Sally (Chief Investigator (CI))
  • Bajel, Ashish (Chief Investigator (CI))
  • Bennet, Samuel (Chief Investigator (CI))
  • Greenwood, Matthew (Chief Investigator (CI))

Project: Research

Project Details

Effective start/end date3/09/2131/12/25


  • Acute lymphoblastic leukaemia (ALL)
  • Chemotherapy
  • Cancer treatment
  • Clinical trial